Recent advances in childhood diabetes mellitus

O O Ayoola1

  • 1Department of Paediatrics, University College Hospital, Ibadan & Endocrine Sciences Research Group, University of Manchester, United Kingdom.

Insights

Type 1 diabetes (T1DM) in children is rising globally. This review covers T1DM advances in causes, treatment, and managing diabetic ketoacidosis to improve child health and prevent complications.

Area of Science:

  • Pediatrics
  • Endocrinology
  • Metabolic Disorders

Background:

  • Diabetes mellitus (DM) is a chronic metabolic disorder due to insulin deficiency, affecting carbohydrate, protein, and fat metabolism.
  • Childhood diabetes presents unique medical and psychosocial challenges, with increasing incidence of both Type 1 (T1DM) and Type 2 (T2DM).
  • T1DM constitutes the majority of childhood diabetes cases, often initially presenting as diabetic ketoacidosis, particularly in regions with low awareness.

Purpose of the Study:

  • To review recent advances in the etiology, pathogenesis, and clinical management of newly diagnosed pediatric T1DM.
  • To provide an overview of optimal growth and development strategies for children with T1DM.
  • To highlight progress in preventing acute and chronic complications associated with childhood T1DM.

Main Methods:

  • Literature review focusing on recent research in pediatric Type 1 diabetes.
  • Analysis of advances in insulin therapy, insulin regimens, and diabetic ketoacidosis management.
  • Exploration of current understanding of T1DM etiology and pathogenesis in children.

Main Results:

  • Significant progress in understanding T1DM etiology and pathogenesis in pediatric populations.
  • Advances in insulin therapy and regimens are improving management of newly diagnosed children.
  • Improved strategies for managing diabetic ketoacidosis and preventing long-term complications.

Conclusions:

  • Continued advances in T1DM management are crucial for ensuring optimal growth and development in affected children.
  • Early diagnosis and comprehensive management, including addressing diabetic ketoacidosis, are key to preventing complications.
  • Ongoing research holds promise for future cures and improved long-term outcomes for pediatric T1DM.

Related Concept Videos

Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1...
39
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
5.4K
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular...
54
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.8K
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the...
18
Diabetes Mellitus: Introduction01:26

Diabetes Mellitus: Introduction

Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and...
17